Stereotaxis, Inc. Common Stock (STXS)
Stereotaxis, Inc. is a medical technology company that specializes in the development and application of robotic systems for minimally invasive cardiac procedures. Founded in 2001, the company focuses on using innovative robotics and imaging technologies to improve the precision, safety, and outcomes of electrophysiology and cardiac surgery interventions. Its flagship product, the Niobe robotic magnetic navigation system, aids physicians in navigating catheters within the heart with enhanced accuracy.
Company News
Stereotaxis will release its Q3 2025 financial results on November 11, 2025, and host a conference call at 4:30 p.m. ET to discuss company results and developments.
Stereotaxis' (STXS) receives updated EU Quality Management System Certificate, which demonstrates compliance with MDR.
Stereotaxis submitted the Magic catheter to EU and US regulators. It plans to submit the semi-mobile robot to regulators in Q2. Read more on SXTS stock here.
The Dow Jones closed lower by around 80 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider tran...
5 hot penny stocks to watch right now. The post 5 Top Penny Stocks To Watch Today; Time To Buy? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.